Biotech · Private company
Latticon Antibody Therapeutics, Inc
Track this companyFree. Adds Latticon Antibody Therapeutics, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- LAT010Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- LAT010 + ICIPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)PHASE1_PHASE2 · RECRUITING · started Jun 5, 2024ClinicalTrials.gov NCT06277219 · fetched Nov 12, 2026